Invasive fungal sinusitis in patients with hematological malignancy: 15 years experience in a single university hospital in Taiwan

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Chen, Chien Yuan ^a   Sheng, Wang Huei ^a   Cheng, Aristine ^a   Chen, Yee Chun ^a   Tsay, Woei ^a   Tang, Jih Luh ^a   Huang, Shang Yi ^a   Chang, Shan Chwen ^a   Tien, Hwei Fang ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Aspergillus galactomanan; Hematological disease; Invasive fungal sinusitis (IFS)

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTINEOPLASTIC AGENT; CASPOFUNGIN; FUNGUS ANTIGEN; GALACTOMANNAN; VORICONAZOLE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; ASPERGILLUS FLAVUS; BONE EROSION; CANCER CLASSIFICATION; CANCER MORTALITY; CHRONIC SINUSITIS; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEBRIDEMENT; DISEASE ASSOCIATION; DISEASE DURATION; DRUG MEGADOSE; FEMALE; FUNGAL SINUSITIS; FUNGUS ISOLATION; HIGH RISK PATIENT; HOSPITAL PATIENT; HUMAN; INFECTION RISK; INVASIVE ASPERGILLOSIS; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MUCORMYCOSIS; NEUTROPENIA; NEUTROPHIL COUNT; NONHUMAN; OUTCOME ASSESSMENT; PROGNOSIS; RETROSPECTIVE STUDY; TAIWAN; UNIVERSITY HOSPITAL; AGED; BLOOD DISEASE; CLASSIFICATION; FUNGUS; IMMUNOCOMPROMISED PATIENT; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MORTALITY; MYCOSIS; PATHOLOGY; RISK ASSESSMENT; SINUSITIS;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FUNGI; HEMATOLOGIC NEOPLASMS; HOSPITALS, UNIVERSITY; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; MYCOSES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SINUSITIS; TAIWAN;

EID: 80053172668     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-250     Document Type: Article

References (29)

1. Crawford J, Dale DC, Lyman GH. Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management. Cancer 2004, 100:228-237. 10.1002/cncr.11882, 14716755.
2. Vento S, Cainelli F. Infections in patients with cancer undergoing chemotherapy: etiology, prevention, and treatment. Lancet Oncol 2003, 4:595-604. 10.1016/S1470-2045(03)01218-X, 14554236.
3. Bow EJ. Management of the febrile neutropenic cancer patient: lessons from 40 years of study. Clin Microbiol Infect 2005, 11(Suppl 5):24-29.
4. Almyroudis NG, Segal BH. Prevention and treatment of invasive fungal diseases in neutropenic patients. Curr Opin Infect Dis 2009, 22:385-393. 10.1097/QCO.0b013e32832e074d, 19506476.
5. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, Denning DW, Donnelly JP, Edwards JE, Erjavec Z, Fiere D, Lortholary O, Maertens J, Meis JF, Patterson TF, Ritter J, Selleslag D, Shah PM, Stevens DA, Walsh TJ, . Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer; Mycoses Study Group of the National Institute of Allergy and Infectious Diseases Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002, 34:7-14. 10.1086/323335, 11731939, Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer; Mycoses Study Group of the National Institute of Allergy and Infectious Diseases.
6. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Muñoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE, . European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008, 46:1813-1821. 10.1086/588660, 2671227, 18462102, European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.
7. Martino R, Subira M. Invasive fungal infections in hematology: new trends. Ann Hematol 2002, 81:233-243. 10.1007/s00277-002-0466-3, 12029531.
8. Anaissie EJ. Diagnosis and therapy of fungal infection in patients with leukemia--new drugs and immunotherapy. Best Pract Res Clin Haematol 2008, 21:683-690. 10.1016/j.beha.2008.10.001, 19041608.
9. deShazo RD, Chapin K, Swain RE. Fungal sinusitis. N Engl J Med 1997, 337:254-259. 10.1056/NEJM199707243370407, 9227932.
10. Parikh SL, Venkatraman G, DelGaudio JM. Invasive fungal sinusitis: a 15-year review from a single institution. Am J Rhinol 2004, 18:75-81.
11. Anselmo-Lima WT, Lopes RP, Valera FC, Demarco RC. Invasive fungal rhinosinusitis in immunocompromised patients. Rhinology 2004, 42:141-144.
12. Howells RC, Ramadan HH. Usefulness of computed tomography and magnetic resonance in fulminant invasive fungal rhinosinusitis. Am J Rhinol 2001, 15:255-261.
13. Chen CY, Tsay W, Tang JL, Tien HF, Chen YC, Chang SC, Hsueh PR. Epidemiology of bloodstream infections in patients with haematological malignancies with and without neutropenia. Epidemiol Infect 2010, 138:1044-1051. 10.1017/S0950268809991208, 19941686.
14. Iwen PC, Rupp ME, Hinrichs SH. Invasive mold sinusitis: 17 cases in immunocompromised patients and review of the literature. Clin Infect Dis 1997, 24:1178-1184. 10.1086/513662, 9195079.
15. Drakos PE, Nagler A, Or R, Naparstek E, Kapelushnik J, Engelhard D, Rahav G, Ne'emean D, Slavin S. Invasive fungal sinusitis in patients undergoing bone marrow transplantation. Bone Marrow Transplant 1993, 12:203-208.
16. Saah D, Drakos PE, Elidan J, Braverman I, Or R, Nagler A. Rhinocerebral aspergillosis in patients undergoing bone marrow transplantation. Ann Otol Rhinol Laryngol 1994, 103:306-310.
17. Talbot GH, Huang A, Provencher M. Invasive aspergillus rhinosinusitis in patients with acute leukemia. Rev Infect Dis 1991, 13:219-232. 10.1093/clinids/13.2.219, 1904160.
18. Weber RS, Lopez-Berestein G. Treatment of invasive Aspergillus sinusitis with liposomal-amphotericin B. Laryngoscope 1987, 97:937-941.
19. Wald A, Leisenring W, van Burik JA, Bowden RA. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 1997, 175:1459-1466. 10.1086/516480, 9180187.
20. Ruhnke M, Böhme A, Buchheidt D, Donhuijsen K, Einsele H, Enzensberger R, Glasmacher A, Gümbel H, Heussel CP, Karthaus M, Lambrecht E, Südhoff T, Szelényi H, . Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO) Diagnosis of invasive fungal infections in hematology and oncology--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 2003, 82(Suppl 2):S141-148. Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
21. Lanza DC, Dhong HJ, Tantilipikorn P, Tanabodee J, Nadel DM, Kennedy DW. Fungus and chronic rhinosinusitis: from bench to clinical understanding. Ann Otol Rhinol Laryngol 2006, 196(Suppl):27-34.
22. Li Y, Li Y, Li P, Zhang G. Diagnosis and endoscopic surgery of chronic invasive fungal rhinosinusitis. Am J Rhinol Allergy 2009, 23:622-625. 10.2500/ajra.2009.23.3361, 19793417.
23. Ingley AP, Parikh SL, DelGaudio JM. Orbital and cranial nerve presentations and sequelae are hallmarks of invasive fungal sinusitis caused by Mucor in contrast to Aspergillus. Am J Rhinol 2008, 22:155-158. 10.2500/ajr.2008.22.3141, 18416972.
24. Krishnan S, Manavathu EK, Chandrasekar PH. Aspergillus flavus: an emerging non-fumigatus Aspergillus species of significance. Mycoses 2009, 52:206-22. 10.1111/j.1439-0507.2008.01642.x, 19207851.
25. Surya Prakash Rao G, Mann SB, Talwar P, Arora MM. Primary mycotic infection of paranasal sinuses. Mycopathologia 1984, 84:73-76. 10.1007/BF00436515, 6425695.
26. Bethge WA, Schmalzing M, Stuhler G, Schumacher U, Kröber SM, Horger M, Einsele H, Kanz L, Hebart H. Mucormycoses in patients with hematologic malignancies: an emerging fungal infection. Haematologica 2005, 90(Suppl):ECR22.
27. Nosari A, Oreste P, Montillo M, Carrafiello G, Draisci M, Muti G, Molteni A, Morra E. Mucormycosis in hematologic malignancies: an emerging fungal infection. Haematologica 2000, 85:1068-1071.
28. Suslu AE, Ogretmenoglu O, Suslu N, Yucel OT, Onerci TM. Acute invasive fungal rhinosinusitis: our experience with 19 patients. Eur Arch Otorhinolaryngol 2009, 266:77-82. 10.1007/s00405-008-0694-9, 18470528.
29. Hachem RY, Boktour MR, Hanna HA, Husni R, Hanna EY, Keutgen X, Shukrallah B, Raad II. Sinus surgery combined with antifungal therapy is effective in the treatment of invasive Aspergillus sinusitis in neutropenic patients with cancer. Infection 2008, 36:539-542. 10.1007/s15010-008-7388-5, 18726553.